These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 1351088

  • 1. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
    Liu AY, Miskovsky EP, Stanhope PE, Siliciano RF.
    J Immunol; 1992 Jun 15; 148(12):3789-98. PubMed ID: 1351088
    [Abstract] [Full Text] [Related]

  • 2. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.
    J Immunol; 1993 May 15; 150(10):4672-86. PubMed ID: 8097759
    [Abstract] [Full Text] [Related]

  • 3. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP, Liu AY, Pavlat W, Viveen R, Stanhope PE, Finzi D, Fox WM, Hruban RH, Podack ER, Siliciano RF.
    J Immunol; 1994 Sep 15; 153(6):2787-99. PubMed ID: 7915742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM, Reade JL, Ware CF, Devlin PE, Liang CM, Devlin JJ.
    J Immunol; 1986 Dec 01; 137(11):3488-93. PubMed ID: 2431035
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ, Norihisa Y, Ortaldo JR.
    J Immunol; 1992 Jan 01; 148(1):55-62. PubMed ID: 1345790
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM, Rowell JF, Soloski MJ, Machamer CE, Siliciano RF.
    J Immunol; 1993 Sep 15; 151(6):2928-42. PubMed ID: 8376762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA, Schwartz DH, Fabry JA, Lieberman J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):27-35. PubMed ID: 7648281
    [Abstract] [Full Text] [Related]

  • 13. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G, Malorni W, Donelli G.
    Ann Ist Super Sanita; 1990 Sep 01; 26(3-4):369-84. PubMed ID: 2151107
    [Abstract] [Full Text] [Related]

  • 14. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW, Kaper BP, Fitch FW.
    J Immunol; 1989 Jan 15; 142(2):416-24. PubMed ID: 2492047
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA.
    J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    Kent SJ, Greenberg PD, Hoffman MC, Akridge RE, McElrath MJ.
    J Immunol; 1997 Jan 15; 158(2):807-15. PubMed ID: 8992998
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS, Berger AE, Ware CF.
    J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.